---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-126671"
form_type: "8-K"
ticker: "DBVT"
cik: "0001613780"
company_name: "DBV Technologies S.A."
filed_at: "2026-03-26T23:59:59+00:00"
generated_at: "2026-05-15T08:50:12.708023+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# DBV Technologies FY2025 net loss $147M; cash runway into Q2 2027; BLA on track H1 2026

## Summary
- Net loss of $147M for FY2025, compared to $113.9M in FY2024; diluted EPS -$1.05.
- Operating income $5.6M, up from $4.2M; R&D expenses rose to $116.7M due to pre-commercial inventory and clinical costs.
- Cash and equivalents $194.2M as of Dec 31, 2025; additional $94M received Jan 2026; funding into Q2 2027.
- BLA submission for VIASKIN Peanut Patch in children aged 4-7 years anticipated H1 2026; for toddlers 1-3 years H2 2026.
- Appointed Kevin Trapp as CCO and James Briggs as CHRO; Philina Lee nominated to Board.

## SEC filing metadata
- accession: 0001193125-26-126671
- form_type: 8-K
- ticker: DBVT
- cik: 0001613780
- company_name: DBV Technologies S.A.
- filed_at: 2026-03-26T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613780/000119312526126671/0001193125-26-126671-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613780/000119312526126671/d113165d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-126671
- JSON: https://secwatch.observer/filing/0001193125-26-126671.json
- Plain text: https://secwatch.observer/filing/0001193125-26-126671.txt

## Key facts
- Earnings Releases
  DBV Technologies S.A. reported the fiscal year ended December 31, 2025 results: net income $147.0 million, EPS $1.05.
  - Period: the fiscal year ended December 31, 2025
  - Net income: $147.0 million
  - EPS: $1.05
  - Result: reported results
  source text: Net loss was $147.0 million for the year ended December 31, 2025, compared to $113.9 million for the year ended December 31, 2024. Net loss per share (based on the weighted average number of shares outstanding over the period) was $1.05 and $1.17 for the year ended December 31, 2025 and 2024, respectively.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1613780/000119312526126671/0001193125-26-126671-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.